Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19
By
Sachin J Shah,
Peter N Barish,
Priya A Prasad,
Amy Kistler,
Norma F. Neff,
Jack Kamm,
Lucy M Li,
Charles Y Chiu,
Jennifer M Babick,
Margaret C Fang,
Yumiko Abe-Jones,
Narges Alipanah,
Francisco N. Alvarez,
Olga B Botvinnik,
Jennifer M. Davis,
Gloria D Castenada,
CLIAHub Consortium,
Rand M Dadasovich,
Xianding Deng,
Joseph L. Derisi,
Angela M. Detweiler,
Scot Federman,
John R Haliburton,
Samantha L Hao,
Andrew D Kerkhoff,
Renuka Kumar,
Katherine Malcolm,
Sabrina A Mann,
Sandra P Martinez,
Rupa Marya,
Eran Mick,
Lusajo L Mwakibete,
Nader Najafi,
Michael J. Peluso,
Maira S Phelps,
Angela O. Pisco,
Kalani Ratnasiri,
Luis A Rubio,
Anna B Sellas,
Kyla D Sherwood,
Jonathan Sheu,
Natasha Spottiswoode,
Michelle Tan,
Guixa Yu,
Kirsten N Kangelaris,
Charles Langelier
Posted 06 May 2020
medRxiv DOI: 10.1101/2020.05.02.20082461
Background: Emerging data on the clinical presentation, diagnostics, and outcomes of patients with COVID-19 have largely been presented as case series. Few studies have compared these clinical features and outcomes of COVID-19 to other acute respiratory illnesses. Methods: We examined all patients presenting to an emergency department in San Francisco, California between February 3 and March 31, 2020 with an acute respiratory illness who were tested for SARS-CoV-2. We determined COVID-19 status by PCR and metagenomic next generation sequencing (mNGS). We compared demographics, comorbidities, symptoms, vital signs, and laboratory results including viral diagnostics using PCR and mNGS. Among those hospitalized, we determined differences in treatment (antibiotics, antivirals, respiratory support) and outcomes (ICU admission, ICU interventions, acute respiratory distress syndrome, cardiac injury). Findings: In a cohort of 316 patients, 33 (10%) tested positive for SARS-CoV-2; 31 patients, all without COVID-19, tested positive for another respiratory virus (16%). Among patients with additional viral testing, no co-infections with SARS-CoV-2 were identified by PCR or mNGS. Patients with COVID-19 reported longer symptoms duration (median 7 vs. 3 days), and were more likely to report fever (82% vs. 44%), fatigue (85% vs. 50%), and myalgias (61% vs 27%); p<0.001 for all comparisons. Lymphopenia (55% vs 34%, p=0.018) and bilateral opacities on initial chest radiograph (55% vs. 24%, p=0.001) were more common in patients with COVID-19. Patients with COVID-19 were more often hospitalized (79% vs. 56%, p=0.014). Of 186 hospitalized patients, patients with COVID-19 had longer hospitalizations (median 10.7d vs. 4.7d, p<0.001) and were more likely to develop ARDS (23% vs. 3%, p<0.001). Most comorbidities, home medications, signs and symptoms, vital signs, laboratory results, treatment, and outcomes did not differ by COVID-19 status. Interpretation: While we found differences in clinical features of COVID-19 compared to other acute respiratory illnesses, there was significant overlap in presentation and comorbidities. Patients with COVID-19 were more likely to be admitted to the hospital, have longer hospitalizations and develop ARDS, and were unlikely to have co-existent viral infections. These findings enhance understanding of the clinical characteristics of COVID-19 in comparison to other acute respiratory illnesses.
Download data
- Downloaded 2,016 times
- Download rankings, all-time:
- Site-wide: 7,306
- In infectious diseases: 1,007
- Year to date:
- Site-wide: 12,308
- Since beginning of last month:
- Site-wide: 14,467
Altmetric data
Downloads over time
Distribution of downloads per paper, site-wide
PanLingua
News
- 27 Nov 2020: The website and API now include results pulled from medRxiv as well as bioRxiv.
- 18 Dec 2019: We're pleased to announce PanLingua, a new tool that enables you to search for machine-translated bioRxiv preprints using more than 100 different languages.
- 21 May 2019: PLOS Biology has published a community page about Rxivist.org and its design.
- 10 May 2019: The paper analyzing the Rxivist dataset has been published at eLife.
- 1 Mar 2019: We now have summary statistics about bioRxiv downloads and submissions.
- 8 Feb 2019: Data from Altmetric is now available on the Rxivist details page for every preprint. Look for the "donut" under the download metrics.
- 30 Jan 2019: preLights has featured the Rxivist preprint and written about our findings.
- 22 Jan 2019: Nature just published an article about Rxivist and our data.
- 13 Jan 2019: The Rxivist preprint is live!